UBS Maintains Neutral on RXO, Raises Price Target to $26

Benzinga Newsdesk www.benzinga.com Positive 51.1%

Neg 0% Neu 0% Pos 51.1%

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $22 to $26.

Comments

No comments yet. Be the first!